Insider Transactions in Q4 2022 at Immunity Bio, Inc. (IBRX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2022
|
Richard Adcock CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,273
-2.87%
|
$21,365
$5.07 P/Share
|
|
Dec 31
2022
|
Richard Adcock CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
8,620
+5.48%
|
-
|
|
Dec 31
2022
|
David C. Sachs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,598
+12.9%
|
-
|
|
Dec 12
2022
|
Patrick Soon Shiong Director |
BUY
Conversion of derivative security
|
Indirect |
9,986,920
+50.0%
|
$49,934,600
$5.67 P/Share
|